Cat.#: ACPP-1641
| Despition | Adenylate cyclase 1 Blocking Peptide |
| SIZE | 250 µg |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1288 | C9orf72 Blocking Peptide (AC1288) | 250 µg | inquiry |
| ACPP-1734 | Human EFNA3 Protein (AC1734) | 5 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1452 | Human HSD17B1 Protein (AC1452) | 2 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.